Payment of research subjects for more than minimal risk trials is unethical

American Journal of the Medical Sciences

Volumn 342, Issue 4, 2011, Pages 294-296

  Wong, Janice C ^a   Bernstein, Mark ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Informed consent; Payment; Qualitative research; Research participation; Undue influence

Indexed keywords

CONFERENCE PAPER; FINANCIAL MANAGEMENT; HUMAN; MORALITY; QUALITATIVE RESEARCH; RESEARCH ETHICS; RESEARCH SUBJECT; RISK BENEFIT ANALYSIS; SOCIAL JUSTICE;

EID: 80053356611     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318227e0a1     Document Type: Conference Paper

References (18)

1. Grady C, Dickert N, Jawetz T, et al. An analysis of U.S. practices of paying research subjects. Contemp Clin Trials 2005;26:365-75. (Pubitemid 40725999)
2. Mazzucca SA, Brandt KD, Katz BP, et al. Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug. Arthritis Rheum 2004;51:933-40. (Pubitemid 39648185)
3. Associated Press. Scientists to pay volunteers thousands to be exposed to deadliest form of malaria. Available at: http://www.foxnews.com/ story/0,2933,335430,00.html. Accessed September 9, 2010.
4. Bernstein M. Payment of research subjects involved in clinical trials is unethical. J Neurooncol 2003;63:223-4. (Pubitemid 36874006)
5. Grady C. Money for research participation: does it jeopardize informed consent? Am J Bioeth 2001;1:40-4.
6. Casarett D, Karlawish J, Asch DA. Paying hypertension research subjects. J Gen Intern Med 2002;17:650-2.
7. Chambers T. Participation as commodity, participation as a gift. Am J Bioeth 2001;1:48.
8. Kuczewski M. Is informed consent enough? Monetary incentives for research participation and the integrity of biomedicine. Am J Bioeth 2001;1:49-51.
9. Mugerwa RD, Kalebu P, Mugyenyi P, et al. First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ 2002;324:226-9. (Pubitemid 34107094)
10. Ballantyne A. Benefits to research subjects in international trials: do they reduce exploitation or increase undue influence? Dev World Bioethics 2008;8:178-91.
11. Dickert N, Grady C. Whats the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999; 341:198-203. (Pubitemid 29325751)
12. Stones M, McMillan J. Payment for participation in research: a pursuit for the poor? J Med Ethics 2010;36:34-6.
13. Lemmens T, Elliott C. Guinea pigs on the payroll: the ethics of paying research subjects. Account Res 1999;7:3-20.
14. Czarny MJ, Kass NE, Flexner C, et al. Payment to healthy volunteers in clinical research: the research subjects perspective. Clin Pharmacol Ther 2010;87:286-93.
15. Weise KL, Smith ML, Maschke KJ, et al. National practices regarding payment to research subjects for participating in pediatric research. Pediatrics 2002;110:577-82. (Pubitemid 34976689)
16. Cryder CE, London AJ, Volpp KG, et al. Informative inducement: study payment as a signal of risk. Soc Sci Med 2010;70:455-64.
17. Dunn LB, Kim DS, Fellows IE, et al. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull 2009;35:730-7.
18. Halpern SD, Karlawish JH, Casarett D, et al. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med 2004;164:801-3. (Pubitemid 38478704)